Trial intelligence / Profile preview

Decitabine Before Allo-HSCT for MDS and AML

NCT01806116Phase 4Unknown

Sponsor
First Affiliated Hospital of Soochow University
Start
Sep 2009
Primary completion
Mar 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of decitabine in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.

02

Drugs

decitabine
03

Conditions

myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)

Beyond the preview

Go deeper on NCT01806116.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01806116.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call